Quantification of Lyssavirus-Neutralizing Antibodies Using Vesicular Stomatitis Virus Pseudotype Particles.

scientific article published on 16 September 2016

Quantification of Lyssavirus-Neutralizing Antibodies Using Vesicular Stomatitis Virus Pseudotype Particles. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3390/V8090254
P8608Fatcat IDrelease_laukbugvlfg2dmyzjtnvr4lmem
P932PMC publication ID5035968
P698PubMed publication ID27649230

P50authorKarl-Klaus ConzelmannQ30002171
Gert ZimmerQ38804568
P2093author name stringSamira Locher
Sarah Moeschler
Beate Krämer
P2860cites workCorrection: Estimating the global burden of endemic canine rabiesQ21144474
Fatal human infection with rabies-related Duvenhage virus, South AfricaQ24628684
Taxonomy of the order Mononegavirales: update 2016Q28275807
Cross-neutralization of antibodies induced by vaccination with Purified Chick Embryo Cell Vaccine (PCECV) against different Lyssavirus speciesQ30875451
A vesicular stomatitis virus replicon-based bioassay for the rapid and sensitive determination of multi-species type I interferonQ31037459
A novel rapid fluorescent focus inhibition test for rabies virus using a recombinant rabies virus visualizing a green fluorescent proteinQ31150358
The rhabdoviruses: biodiversity, phylogenetics, and evolutionQ33449999
Rabies-specific antibodies: measuring surrogates of protection against a fatal diseaseQ33541002
Collaborative study for validation of a serological potency assay for rabies vaccine (inactivated) for veterinary useQ82817379
The rapid fluorescent focus inhibition test is a suitable method for batch potency testing of inactivated rabies vaccinesQ83269151
Generation of recombinant rabies Virus CVS-11 expressing eGFP applied to the rapid virus neutralization testQ33584768
Evidence of two Lyssavirus phylogroups with distinct pathogenicity and immunogenicityQ33838289
A Fatal Human Infection with Mokola Virus *Q34215531
Rabies virus glycoprotein. II. Biological and serological characterizationQ34408674
Rabies re-examinedQ34764816
A recombinant rabies virus expressing a phosphoprotein-eGFP fusion is rescued and applied to the rapid virus neutralization antibody assayQ35595566
Development and Applications of VSV Vectors Based on Cell TropismQ35679152
Re-evaluating the burden of rabies in Africa and Asia.Q36174024
Genomic diversity and evolution of the lyssavirusesQ36575472
A robust lentiviral pseudotype neutralisation assay for in-field serosurveillance of rabies and lyssaviruses in AfricaQ37461555
Human rabies due to lyssavirus infection of bat originQ37699593
Rabies virus vaccines: is there a need for a pan-lyssavirus vaccine?Q38053739
Australian Bat Lyssavirus in a child: the first reported caseQ38192973
Current status of rabies and prospects for eliminationQ38211810
G gene-deficient single-round rabies viruses for neuronal circuit analysisQ38525112
Chimeric rabies viruses for trans-species comparison of lyssavirus glycoprotein ectodomain functions in virus replication and pathogenesisQ39328640
Mokola virus glycoprotein and chimeric proteins can replace rabies virus glycoprotein in the rescue of infectious defective rabies virus particles.Q39869015
A recombinant vesicular stomatitis virus replicon vaccine protects chickens from highly pathogenic avian influenza virus (H7N1).Q39897024
Concepts in the pathogenesis of rabiesQ39965361
A rapid reproducible test for determining rabies neutralizing antibodyQ40870187
Molecular cloning and complete nucleotide sequence of the attenuated rabies virus SAD B19.Q41739249
Monte Carlo simulation of the Spearman-Kaerber TCID50.Q42536190
Conformation-dependent accessibility of the linear epitopes located on the rabies virus glycoproteinQ42604413
Comparative analysis of the full genome sequence of European bat lyssavirus type 1 and type 2 with other lyssaviruses and evidence for a conserved transcription termination and polyadenylation motif in the G-L 3' non-translated regionQ42615215
Complete genomes of Aravan, Khujand, Irkut and West Caucasian bat viruses, with special attention to the polymerase gene and non-coding regionsQ42657452
Antigenic and functional analyses of glycoprotein of rabies virus using monoclonal antibodiesQ44937479
Fusion-active glycoprotein G mediates the cytotoxicity of vesicular stomatitis virus M mutants lacking host shut-off activityQ45374488
Use of influenza C virus glycoprotein HEF for generation of vesicular stomatitis virus pseudotypesQ45481602
Development of a fluorescent antibody virus neutralisation test (FAVN test) for the quantitation of rabies-neutralising antibodyQ45754757
Case report: isolation of a European bat lyssavirus type 2a from a fatal human case of rabies encephalitisQ48218249
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue9
P921main subjectvesicular stomatitisQ11549084
P577publication date2016-09-16
P1433published inVirusesQ7935305
P1476titleQuantification of Lyssavirus-Neutralizing Antibodies Using Vesicular Stomatitis Virus Pseudotype Particles
P478volume8

Reverse relations

cites work (P2860)
Q549768771-Benzyl-3-cetyl-2-methylimidazolium Iodide (NH125) Is a Broad-Spectrum Inhibitor of Virus Entry with Lysosomotropic Features.
Q60955902A high throughput neutralization test based on GFP expression by recombinant rabies virus
Q47568014Current status on the development of pseudoviruses for enveloped viruses
Q59792289Establishment of a Chinese street rabies virus library and its application for detecting neutralizing activity
Q41927480Oxidation-sensitive polymersomes as vaccine nanocarriers enhance humoral responses against Lassa virus envelope glycoprotein
Q64360174Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting
Q99728288Quantification of SARS-CoV-2 neutralizing antibody by a pseudotyped virus-based assay
Q39393526Rabies - epidemiology, pathogenesis, public health concerns and advances in diagnosis and control: a comprehensive review

Search more.